Search 

Novo Seeds is a life science supporting program launched by the Novo Nordisk Foundation and Novo A/S. Novo Seeds has two components, a pre-seed funding capacity and a seed financing fund. Both aim at identifying and developing the unexplored commercial potential present in academic and early stage applied research projects at universities and biotech companies within life science in Scandinavia.

The pre-seed program supports early stage projects based on ideas and results with commercial potential. Funding is given as grants in the same manner as other grants awarded by the Novo Nordisk Foundation.

The seed fund aims at supporting more advanced projects and will operate on commercial terms, i.e. support is given to projects and companies in exchange for ownership or other rights to the companies/projects. Typically, the seed program will invest in newly formed companies that are too early in their development stage to be supported by Novo A/S’ venture capital or other international investors

SEED Capital is the largest early stage venture fund in Denmark. We invest in companies within IT, Cleantech and Life Science at the seed or even pre-seed stage from Denmark and southern Sweden. We invest in classic venture companies that have a highly innovative solution and a scalable business model for entering an attractive market with a number of identified paths to exit.

Because of our strong partnership with the government funded innovation incubator DTU Symbion Innovation we are able to invest € 250-750.000 at the early stages of a company’s development, allowing them an opportunity to prove their technology and business.

Depending on capital need, SEED Capital can invest up to € 9 million in the following rounds – preferably in syndication with international investors. We take an active advisory role as an investor and will normally take the position of Chairman of the Board in the company until a skilled alternative is identified.

Serendipity's core business is to create new innovative companies based on leading academic research.

Serendipity does this together with leading researchers, motivated entrepreneurs and by working closely with potential customers to ensure that the products and services developed meet the actual needs and requirements of the market. Our product development projects usually involve paying customers. This makes the value creation process more efficient while the product demand becomes more predictable.  

Serendipity began operations in 2004 and has since established and operated more than ten companies; most of them research and development-intensive companies.